Cure My Disease

Don't miss your cure!

 Log in / Sign up

New Two-Drug attack on advanced lung cancer enters major global trial

NCT ID NCT07005102

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

Summary

This study is testing whether adding a new investigational drug, telisotuzumab adizutecan, to an approved lung cancer drug (osimertinib) works better than the current standard treatment. It is for adults with a specific type of advanced lung cancer that has spread and has an EGFR gene mutation. The goal is to find the best dose and see if this combination can better control the cancer's growth and help patients live longer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SQUAMOUS NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AZ-Delta. /ID# 275753

    RECRUITING

    Roeselare, West-Vlaanderen, 8800, Belgium

  • Asan Medical Center /ID# 275600

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 05505, South Korea

  • Austin Health /ID# 275505

    RECRUITING

    Heidelberg, Victoria, 3084, Australia

  • Chungbuk National University Hospital /ID# 275768

    RECRUITING

    Cheongju-si, North Chungcheong, 28644, South Korea

  • Hospital Clinic de Barcelona /ID# 275476

    RECRUITING

    Barcelona, 08036, Spain

  • Hospital Cuf Porto /ID# 275395

    RECRUITING

    Porto, 4100-180, Portugal

  • Hospital General Universitario Gregorio Maranon /ID# 275475

    RECRUITING

    Madrid, 28007, Spain

  • IRCCS Istituti Fisioterapici Ospitalieri-Istituto Nazionale Tumori Regina Elena /ID# 274948

    RECRUITING

    Rome, Roma, 00144, Italy

  • Inje University Haeundae Paik Hospital /ID# 275388

    RECRUITING

    Busan, Busan Gwang Yeogsi, 48108, South Korea

  • Instituto Valenciano de Oncología /ID# 275471

    RECRUITING

    Valencia, 46009, Spain

  • Jessa Ziekenhuis - Campus Virga Jesse /ID# 275585

    RECRUITING

    Hasselt, Limburg, 3500, Belgium

  • Juntendo University Hospital /ID# 276424

    RECRUITING

    Bunkyo-ku, Tokyo, 113-8431, Japan

  • Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 275293

    RECRUITING

    Kaohsiung City, 807, Taiwan

  • Liverpool Hospital /ID# 276304

    RECRUITING

    Liverpool, New South Wales, 2170, Australia

  • Mid Florida Hematology And Oncology Center /ID# 275278

    RECRUITING

    Orange City, Florida, 32763, United States

  • National Cancer Center Hospital /ID# 275678

    RECRUITING

    Chuo-Ku, Tokyo, 104-0045, Japan

  • National Cancer Centre Singapore /ID# 275986

    RECRUITING

    Singapore, Central Singapore, 169611, Singapore

  • National Taiwan University Cancer Center (Ntucc) /ID# 275291

    RECRUITING

    Taipei, 106, Taiwan

  • National University Hospital /ID# 275988

    RECRUITING

    Singapore, 119074, Singapore

  • Nho - Revive Research Institute /ID# 276115

    RECRUITING

    Lincoln, Nebraska, 68506, United States

  • Niigata University Medical & Dental Hospital /ID# 275685

    RECRUITING

    Niigata, Niigata, 951-8520, Japan

  • Osaka Medical And Pharmaceutical University Hospital /ID# 275684

    RECRUITING

    Takatsuki, Osaka, 569-8686, Japan

  • Rabin Medical Center. /ID# 274540

    RECRUITING

    Petah Tikva, 4941492, Israel

  • Rambam Health Care Campus- Haifa /ID# 274542

    RECRUITING

    Haifa, 3525408, Israel

  • Renown Regional Medical Center /ID# 276049

    RECRUITING

    Reno, Nevada, 89502, United States

  • Samsung Medical Center /ID# 278083

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 06351, South Korea

  • St John Of God Murdoch Hospital /ID# 275700

    RECRUITING

    Murdoch, Western Australia, 6150, Australia

  • Taipei Veterans General Hospital /ID# 275292

    RECRUITING

    Taipei, 112, Taiwan

  • Texas Oncology - Palestine Cancer Center /ID# 276034

    RECRUITING

    Palestine, Texas, 75801, United States

  • Texas Oncology - South Austin /ID# 276033

    RECRUITING

    Austin, Texas, 78745, United States

  • The Chaim Sheba Medical Center /ID# 274541

    RECRUITING

    Ramat Gan, Tel Aviv, 5265601, Israel

  • The Iowa Clinic /ID# 276020

    RECRUITING

    West Des Moines, Iowa, 50266, United States

  • The Queen Elizabeth Hospital /ID# 275719

    RECRUITING

    Woodville, South Australia, 5011, Australia

  • The University of Texas MD Anderson Cancer Center /ID# 275107

    RECRUITING

    Houston, Texas, 77030, United States

  • USC Norris Comprehensive Cancer Center /ID# 275343

    RECRUITING

    Los Angeles, California, 90033, United States

  • Unidade Local de Saude de Braga, EPE /ID# 275394

    RECRUITING

    Braga, 4710-243, Portugal

  • Unidade Local de Saude de Santo Antonio, E.P.E. /ID# 275387

    RECRUITING

    Porto, 4099-003, Portugal

  • Universitair Ziekenhuis Leuven /ID# 275586

    RECRUITING

    Leuven, Vlaams-Brabant, 3000, Belgium

  • University Colorado Cancer Center /ID# 275382

    RECRUITING

    Aurora, Colorado, 80045-2517, United States

  • Usc Norris Oncology/Hematology Treatment Center /ID# 278673

    RECRUITING

    Newport Beach, California, 92663, United States

  • Virginia Cancer Specialists - Fairfax /ID# 275071

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • Yokohama Municipal Citizen's Hospital /ID# 275682

    RECRUITING

    Yokohama, Kanagawa, 221-0855, Japan

  • Yonsei University Health System Severance Hospital /ID# 275384

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 03722, South Korea

Conditions

Explore the condition pages connected to this study.

NON-SQUAMOUS NON-SMALL CELL LUNG CANCER